← FDA Drug Approvals (Drugs@FDA)

ETODOLAC

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMACO · Approved 2020-12-16

Drug application

FDA Application #

ANDA210704

Application type

Abbreviated New Drug Application (Generic)

Brand name

ETODOLAC

Generic name

ETODOLAC

Active ingredients

ETODOLAC

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

PHARMACO

Manufacturer

Unichem Pharmaceuticals (USA), Inc.

First approval

2020-12-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown